Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2010-08-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Pulsed dye laser is a type of laser that is commonly used to treat lesions on the skin that have a prominent blood vessel component. It has been used to treat broken blood vessels on the face, hemangiomas in children and adults, leg veins, port wine stains, and other lesions with a prominent vascular component.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ
NCT03025724
Pilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Systemic Scleroderma
NCT05036200
Photodynamic Therapy in Treating Patients With Skin Cancer
NCT00002963
Dermatosis Papulosa Nigra
NCT00710203
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study
NCT04249115
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
No treatment administered
No interventions assigned to this group
PDL Setting 1
PDL Setting 1: 15 J/cm2, 3ms pulse length, no dynamic cooling, 7mm spot size, 10% overlap between the pulses, 2 passes
PDL Treatment
Pulsed-dye laser (PDL) treatment at one of two settings.
PDL Setting 2
PDL Setting 2: 7.5 J/cm2, 3ms pulse length, no dynamic cooling, 10mm spot size, 10% overlap between the pulses, 2 stacked pulses
PDL Treatment
Pulsed-dye laser (PDL) treatment at one of two settings.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PDL Treatment
Pulsed-dye laser (PDL) treatment at one of two settings.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lesions in the Trunk, Extremities, and Scalp
* Presence of clinically identifiable residual tumor.
* Patients, males and females, aged 18-90 years.
* Willing to participate.
* Able to give informed consent.
Exclusion Criteria
* Location of lesion not in the Trunk, Extremities, and Scalp
* Fitzpatrick skin type V or VI.
* Prior history of known light sensitivity.
* Pregnancy
* Cognitive Impairment
* Prisoner
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Diego
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Shang I. Brian Jiang
Clinical Professor of Dermatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
S. I. Brian Jiang, MD
Role: PRINCIPAL_INVESTIGATOR
UCSD Medical Center, Division of Dermatology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HRPP-101001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.